Catheter-Directed Thrombolysis Devices Market Share, Report, Forecast 2024-2032

IMARC Group, a leading market research company, has recently releases report titled “Catheter-Directed Thrombolysis Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global catheter-directed thrombolysis devices market share, size, growth, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Catheter-Directed Thrombolysis Devices

Catheter-directed thrombolysis (CDT) devices are medical instruments that are manufactured with precision to address thrombosis, a condition characterized by the formation of blood clots within blood vessels. They offer a minimally invasive (MI) approach to dissolve blood clots effectively as compared to conventional open surgical procedures. They require only a small incision for catheter insertion, reduce pain, and provide faster recovery times for patients. They enable highly targeted therapy and allow for the direct delivery of thrombolytic drugs. They ensure a higher success rate in clot dissolution and lower the chances of clot fragments traveling to other parts of the body. They assist in lowering the risk of complications, such as infection and excessive bleeding among individuals. As they reduce healthcare costs and provide safety to patients, the demand for CDT devices is increasing across the globe.   

How Big Is the Catheter-Directed Thrombolysis Devices Market?

The global catheter-directed thrombolysis devices market size reached US$ 376.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 581.3 Million by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032.

Request Sample Copy of This Report:

What are the growth prospects and trends in the catheter-directed thrombolysis devices industry?

At present, the rising adoption of modern CDT devices that have imaging capabilities and allow healthcare providers to monitor the clot dissolution process in real-time represents one of the major factors strengthening the growth of the market. Besides this, the escalating demand for advanced treatment options among the geriatric population, as they are more prone to conditions associated with vascular issues, is offering a positive market outlook.

In addition, increasing preferences for minimally invasive (MI) procedures among patients is impelling the market growth. Apart from this, the rising prevalence of vascular diseases, such as deep vein thrombosis (DVT) and pulmonary embolism, among individuals is offering lucrative growth opportunities to industry investors. Moreover, the growing demand for CDT devices for improved patient outcomes and satisfaction is positively influencing the market.

In line with this, the increasing focus on patient-centric care in healthcare facilities is propelling the market growth. Furthermore, innovations in catheter design, drug delivery systems, and imaging technologies enhance the effectiveness and safety of CDT devices, which is contributing to the market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Delivery Mode:

  • Directly Delivery to Blood Clot
  • Positioning Medical Device at Clot Site

Breakup by Indication:

  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Stroke
  • Others

Breakup by End User:

  • Hospitals
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Inari Medical, Inc.
  • iVascular, S.L.U
  • Medtronic Plc
  • Penumbra, Inc.
  • Straub Medical AG (Becton, Dickinson, and Company)
  • Teleflex Incorporated
  • Thrombolex Inc. 

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

Electrophotographic Printing Market Trends, Report and Industry Growth Forecast 2023-2028

Leave a Reply

Your email address will not be published. Required fields are marked *